Amoroso Michael 4
4 · PRECISION BIOSCIENCES INC · Filed Mar 25, 2025
Insider Transaction Report
Form 4
Amoroso Michael
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-21−3,417→ 0 total→ Common Stock (3,417 underlying) - Exercise/Conversion
Common Stock
2025-03-21+3,417→ 110,504 total - Sale
Common Stock
2025-03-24$5.56/sh−964$5,360→ 109,540 total
Footnotes (4)
- [F1]Represents the vesting of Restricted Stock Units ("RSUs") on March 21, 2025.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F4]On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 21, 2025.